Literature DB >> 8741945

Movements in never-medicated schizophrenics: a preliminary study.

D S Fenn1, D Moussaoui, W F Hoffman, N Kadri, B Bentounssi, A Tilane, M Khomeis, D E Casey.   

Abstract

Descriptions of schizophrenia dating to the beginning of this century include mention of abnormal movements which are similar to tardive dyskinesia (TD), currently thought to be sequelae of neuroleptic medication. In order to examine the extent to which such movements might appear in the normal course of schizophrenia, we examined a sample of 22 never-medicated DSM-III-R schizophrenics who presented for treatment at a psychiatric center in Casablanca, Morocco. Duration of illness in this sample ranged from 1 to 10 years. Patients were assessed for choreoathetoid movements using the Abnormal Involuntary Movement Scale (AIMS). Videotaped and live examinations were rated by the investigators. Three patients (14%) met research diagnostic criteria for probable SD. Mild movements in one body part (AIMS = 2) were seen in an additional five (23%) patients. The movements were characteristic of TD, although their somatic distribution differed from previous studies. Total AIMS score increased with age and duration of illness (r = 0.64, P < 0.01). These findings suggest that choreoathetoid movements may appear spontaneously in patients with schizophrenia.

Entities:  

Mesh:

Year:  1996        PMID: 8741945     DOI: 10.1007/bf02246179

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients.

Authors:  K W Brown; T White
Journal:  Biol Psychiatry       Date:  1991-12-15       Impact factor: 13.382

Review 2.  Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms.

Authors:  J L Waddington
Journal:  Int Rev Neurobiol       Date:  1989       Impact factor: 3.230

3.  Prevalence of tardive dyskinesia in elderly samples.

Authors:  J Lieberman; J M Kane; M Woerner; P Weinhold
Journal:  Psychopharmacol Bull       Date:  1984

Review 4.  Tardive dyskinesia.

Authors:  J Gerlach
Journal:  Dan Med Bull       Date:  1979-08

5.  Reliability of ICD-10 research criteria: an Arab perspective.

Authors:  A Okasha; A Seif el Dawla
Journal:  Acta Psychiatr Scand       Date:  1992-12       Impact factor: 6.392

6.  A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals.

Authors:  T R Barnes; M Rossor; T Trauer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

7.  Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.

Authors:  J L Waddington; H A Youssef; A G Molloy; K M O'Boyle; M T Pugh
Journal:  J Clin Psychiatry       Date:  1985-04       Impact factor: 4.384

8.  The prevalence of tardive dyskinesia in geropsychiatric outpatients.

Authors:  R C Chacko; L Root; J Marmion; V Molinari; G L Adams
Journal:  J Clin Psychiatry       Date:  1985-02       Impact factor: 4.384

Review 9.  Differential diagnosis of choreiform tardive dyskinesia.

Authors:  T M Hyde; J R Hotson; J E Kleinman
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1991       Impact factor: 2.198

10.  An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.

Authors:  J L Waddington; H A Youssef
Journal:  Am J Psychiatry       Date:  1986-09       Impact factor: 18.112

View more
  7 in total

1.  Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Markus Mittendorf; Frank M Theisen; Karin Wolf-Ostermann; Phillip Grant; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-04-28       Impact factor: 4.785

2.  Involuntary movements and their correlates in first-episode psychoses.

Authors:  Pallav Pareek; Tejas S Bhojraj; Debra M Montrose; Rajaprabhakaran Rajarethinam; John A Sweeney; Matcheri S Keshavan
Journal:  Acta Neuropsychiatr       Date:  2010-10       Impact factor: 3.403

Review 3.  Motor deficits and schizophrenia: the evidence from neuroleptic-naïve patients and populations at risk.

Authors:  A L Wolff; G A O'Driscoll
Journal:  J Psychiatry Neurosci       Date:  1999-09       Impact factor: 6.186

4.  Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Frank M Theisen; Richard von Georgi; Phillip Grant; Markus Mittendorf; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

5.  Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis.

Authors:  Jeroen P F Koning; Diederik E Tenback; Jim van Os; André Aleman; René S Kahn; Peter N van Harten
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

Review 6.  Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology.

Authors:  Peter F Whitty; Olabisi Owoeye; John L Waddington
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

7.  Movement disorders in neuroleptic-naïve patients with schizophrenia spectrum disorders.

Authors:  Moges Ayehu; Teshome Shibre; Barkot Milkias; Abebaw Fekadu
Journal:  BMC Psychiatry       Date:  2014-10-09       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.